CN100379739C - Process for preparing azacycloalkanoylaminothiazoles - Google Patents

Abstract

The present invention describes compounds of formula (I): and enantiomers, diastereomers and pharmaceutically acceptable salts thereof. The formula (I) compounds are protein kinase inhibitors and are useful in the treatment of proliferative diseases, for example, cancer, inflammation and arthritis. They may also be useful in the treatment of Alzheimer's disease, chemotherapy-induced alopecia, and cardiovascular disease.

Description

The method for preparing azacycloalkanoyl aminothiazoles

The application is dividing an application of an application for a patent for invention, and the applying date of its female case is that May 2 calendar year 2001, application number are 01813178.6, denomination of invention is " method for preparing azacycloalkanoyl aminothiazoles ".

Technical field

The present invention relates to prepare 5-(2- azoles base alkylthio)-2-azacycloalkanoyl aminothiazoles and analogue, the novel method of the kinase inhibitor of cyclin dependent.

The 5-of formula I (2- azoles base alkylthio)-2-azacycloalkanoyl aminothiazoles compound or its pharmacy acceptable salt are kinases (cdks) inhibitor new, effective cyclin dependent,

Wherein:

R is alkyl, aryl or heteroaryl;

R ¹, R ², R ³, R ⁴And R ⁵Each independently is hydrogen, alkyl, aryl or heteroaryl;

R ⁶And R ⁷Each independently is hydrogen, alkyl, aryl, heteroaryl, halogen, hydroxyl or alkoxyl group;

R ⁸Be hydrogen, alkyl, aryl, heteroaryl, CONR ⁹R ¹⁰, COR ¹¹Or COOR ¹²

R ⁹, R ¹⁰, R ¹¹And R ¹²Each independently is hydrogen, alkyl or aryl;

M is 0 to 5; With

N is 0 to 5.They are at the treatment proliferative disease, and for example the alopecia that causes of cancer, inflammation, autoimmune disease such as sacroiliitis, virus disease, fungal disease, chemotherapy, neurodegenerative disorders are as being useful in presenile dementia and the cardiovascular disorder.More particularly, formula I compound is used for the treatment of the cancer of various cancers such as bladder, mammary gland, colon, kidney, liver and lung.

Background technology

WO 9924416 and corresponding US numbers 6; 040; 321 have described by 5-ethanoyl sulfo--2-kharophen thiazole and a kind of alkali reaction; hold back the method that the mercaptan ester with 2- azoles base alkylogen prepares 5-(2- azoles base alkylthio)-thiazolamine subsequently, it is the key intermediate of 5-(2- azoles base alkylthio)-2-azacycloalkanoyl aminothiazoles of synthesis type I.5-(2- azoles base alkylthio)-2-kharophen thiazolium compounds that hydrolysis produces obtains 5-(2- azoles base alkylthio)-thiazolamine key intermediate.Reaction by (i) beta-hydroxy amine and α-chlorine chloride of acid, beta-hydroxy-α-the chloro-acid amide that produces with rear oxidation also then forms  azoles ring (K.S.Kim etc., WO9924416, May 20,1999) or (ii) α-diazo ketone and α-chlorine nitrile reaction (K.S.Kim etc., WO 9924416, May 20,1999; T.Ibata etc., Bull.Chem.Soc.Japan 1979,52, and 3597) the essential 2- azoles base alkyl halide of preparation.Though can prepare various 5-(2- azoles base alkylthio)-thiazolamine by this method; but because commercial availability, the use of deleterious α-diazo ketone and the expensive chromatographic separation of product of starting raw material 5-acetyl thio base-2-acetylamino thiazole, this method is not suitable for large-scale synthetic.

Before in document (A.Hassner etc., Angew Chem.Int.Ed.Engl.1986,25,478; M.G.Nair etc., J.Med.Chem.1980,23,899; H.-J.Ha etc., Synth.Commun.1994,24,2557) in the report α-Lu Daitong react with trinitride and obtain α-azido-ketone.Reported also before that the reaction of α-sulfonyloxy ketone and trinitride obtained α-azido-ketone (T.Patonay etc., J.Org.Chem.1994,59,2902; G.A.Revelli etc., SynthCommun.1993,23,1111).

In document (H.-J.Ha etc., Synth.Commun.1994,24,2557; J.P.Sanchez etc., J.Heterocycl.Chem.1988,25,469; S.K.Boyer etc., J.Org.Chem.1985,50,3408) in described α-azido-ketone and be reduced to alpha-amino group ketone.Also described alpha-amino group ketone and obtained corresponding acid amides (G.T.Newbold etc., J.Chem.Soc.1948,1855 with the reaction of alpha-halogen acyl halide; G.T.Newbold etc., J.Chem.Soc.1950,909).

Reported before that the reaction of salt and alkyl halide obtained sulfide (H.Chen etc., Synth.Commun.1990,20,3313) alkyl thiourea  (alkylthiouronium).Reported that the reaction of alkyl sulfhydryl and 5-bromo-thiazolamine obtains 5-alkylthio-thiazolamine (J.B.Dickey etc., J.Org.Chem.1959,24,187).

Summary of the invention

The present invention relates to prepare the new effective ways of 5-(2- azoles base alkylthio)-thiazolamine.This method comprises the New Policy of preparation 2- azoles base alkyl halide and 5-(2- azoles base alkylthio)-thiazolamine, comprises preparing the new key intermediate quaternary ammonium salt and the method for 2- azoles base alkyl sulfur compounds derivative.The invention still further relates to preparation 5-(2- azoles base alkylthio)-2-azacycloalkanoyl aminothiazoles and analogue, the method for the kinase inhibitor of cyclin dependent.

The present invention relates to method new, the more effective 5-of preparation (2- azoles base alkylthio)-thiazolamine; described 5-(2- azoles base alkylthio)-thiazolamine is used for synthetic 5-(2- azoles base alkylthio)-2-azacycloalkanoyl aminothiazoles and analogue, the kinase inhibitor of cyclin dependent.Present method makes usually and comprises that α-Lu Daitong II and trinitride reaction obtain α-azido-ketone III.Obtain alpha-amino group ketone IV with going back original reagent reduction III.From the position of practice, security consideration makes to be reflected at economically by this of trinitride and is difficult to carry out.

Embodiment

As selecting and more preferably, by reactions such as α-Lu Daitong II and a kind of cyclic alkylidene tetramine such as vulkacit Hs, with the new described alpha-amino group ketone of the quaternary ammonium salt III ' preparation IV of posthydrolysis generation.Yet in safer mode, this reaction provides the splendid productive rate of required midbody compound IV, more than 90%.

After this, in the presence of alkali, alpha-amino group ketone IV and alpha-halogen acyl halide V reaction, or optionally, make alpha-amino group ketone IV and alpha-halogen acid coupling, produce corresponding amide VI.Then, make the VI closed loop obtain 2- azoles base alkyl halide VII with dehydrated reagent.When the dehydrated reagent of using a kind of routine as three halo phosphorus oxide such as POCl ₃The time, the separation of product is difficult, because the formation of a large amount of hydrochloric acid and phosphoric acid is arranged.Therefore, method of the present invention is preferably used Burgess ' reagent, and it produces fabulous productive rate and easy, separated product from water safely.

With the reagent VIII or the VIII ' processing 2- azoles base alkyl halide VII of sulfur-bearing, obtain new key intermediate compound, 2- azoles base alkyl sulfur compounds IX subsequently.IX and 5-halo-thiazolamine X coupling obtains 5-(2- azoles base alkylthio)-thiazolamine XI.XI and azacycloalkyl acid derivative XII coupling obtain Thizaolyl amide XIII, and it can go protection (is under the situation of blocking group such as Boc at P) to obtain wherein R ⁷Be 5-(2- azoles base the alkylthio)-2-azacycloalkanoyl aminothiazoles I of hydrogen, the kinase inhibitor of cyclin dependent.

Set forth above-mentioned reaction below in the flow process 1.

Flow process 1

In the formula I-XIII of flow process 1, adopt following term:

R is alkyl, aryl or heteroaryl;

R ¹, R ², R ³, R ⁴And R ⁵Each independently is hydrogen, alkyl, aryl or heteroaryl;

R ⁶And R ⁷Each independently is hydrogen, alkyl, aryl, heteroaryl, halogen, hydroxyl or alkoxyl group;

R ⁸Be hydrogen, alkyl, aryl, heteroaryl, CONR ⁹R ¹⁰, COR ¹¹Or COOR ¹²

R ⁹, R ¹⁰, R ¹¹And R ¹²Each independently is hydrogen, alkyl or aryl;

L is halogen or sulphonate (RSO ₂O-, CF ₃SO ₂O-etc.);

M is hydrogen, Li, Na, K, Cs or quaternary ammonium (R ₄N);

X is hydroxyl, halogen or acyloxy (RCOO-, ROCOO-etc.);

Y is O, S, NH, N-alkyl, N-aryl or N-acyl group;

Z is hydrogen, alkyl, aryl, O-alkyl, O-aryl, S-alkyl, S-aryl, NH ₂, N-alkyl, N-aryl or N-acyl group;

P is nitrogen-blocking group (Boc, Cbz, R ₃Si etc.);

M is 0 to 5; With

N is 0 to 5.

Below list the definition that is used to describe the various terms that comprise compound in the methods of the invention.When they individually or when being used for entire description than the part of macoradical, these definition are applicable to described term (unless specifying in addition).Should be noted that any heteroatoms with unsaturated valency all supposes to have hydrogen atom with saturated valency.

Term " alkyl " or " alkane " (being the derivative of alkyl) refer to contain optional straight chain, side chain or the cyclic unit price alkane (stable hydrocarbon) that replaces of group deutero-of 1 to 12 carbon atom, this group when replacing, four substituting group groups of available as many as substituted alkyl group on any utilizable link position.The example of alkyl group includes, but not limited to methyl, ethyl, propyl group, sec.-propyl, normal-butyl, the tertiary butyl, isobutyl-, amyl group, hexyl, isohexyl, heptyl, octyl group, nonyl, decyl, undecyl, dodecyl etc.Described alkyl can be chosen wantonly by one or more halogens or as trifluoromethyl, 4,4-dimethyl amyl group, 2,2, and the alkyl group of 4-tri-methyl-amyl etc. replaces.

Term " aryl " or the term that derives from thus refer to contain the aromatic nucleus of 6 to 30 carbon atom monocycles or dicyclo, as the phenyl of phenyl, replacement etc., and condensed group such as naphthyl, phenanthryl etc.Therefore an aromatic yl group contains a ring with 6 atoms at least, and there are 5 in this type of ring at most, wherein contains maximum 22 or 30 atoms, depends on the two keys of any change (resonance) between carbon atom or suitable heteroatoms.The example of aromatic yl group includes, but not limited to phenyl, naphthyl, anthryl, xenyl etc.

Term " acyl group " refers to radicals R CO-, separately or with unite existence as oxygen, nitrogen, sulphur etc.Term " halogen " or " halo " refer to chlorine, bromine, fluorine or iodine, and bromine is preferred halogen.

Term " heteroaryl " refers to have the mononuclear aromatics group of 5 or 6 annular atomses, or have 8 to 10 atoms, contain at least one heteroatoms, the Bicyclic group of O, S or N, wherein carbon or nitrogen-atoms are tie points, and one of them or the optional heteroatomss that are selected from O or S of two other carbon atoms replace, and wherein 1 to 3 other carbon atom is optional is replaced by nitrogen heteroatom, described in this, described heteroaryl groups is optionally substituted.Exemplary heteroaryl groups comprises; but be not limited to thienyl, furyl, pyrryl, pyridyl, imidazolyl, pyrrolidyl, piperidyl, thiazolyl,  azoles base, triazolyl, pyrazolyl, different  azoles base, isothiazolyl, pyrazinyl, pyridazinyl, pyrimidyl, triazinyl azepine  base, indyl, pseudoindoyl, quinolyl, isoquinolyl, benzothiazolyl, benzoxazol base, benzimidazolyl-, benzo  di azoly, benzo furazan base etc.Described heteroaryl can be chosen wantonly by one or more groups and replace; described group comprises; but be not limited to halogen, alkyl, alkoxyl group, hydroxyl, carboxyl, formamyl, alkoxy carbonyl, trifluoromethyl, cycloalkyl, nitro, cyano group, amino, alkyl S (O) _m(wherein m=0,1 or 2), thiol etc.

When claiming a functional group be " protected ", mean this group for the form of modifying in case eliminating in the unwanted side reaction of protective position.Consider those skilled in the art's level; the suitable blocking group of the compound that relates in present method will be from this specification sheets; and consult standard textbook such as T.W.Greene etc.; blocking group in organic synthesis (ProtectiveGroups in Organic Synthesis); Wiley, N.Y. learns in (1991).

Term " pharmacy acceptable salt " refers to that those influence described compound pharmaceutical properties indistinctively or on the contrary, as the salt of the bioactive compounds of toxicity, effect etc., and comprises that those conventionally are used for the salt of pharmaceutical industry.The suitable example of salt includes, but not limited to salt example hydrochloric acid salt that those and inorganic or organic acid form, hydrobromate, vitriol, phosphoric acid salt etc.Particularly for midbody compound of the present invention, described salt also comprises and is unsuitable for pharmaceutical use, but can be used for the salt of others, for example the isolation and purification of free active compound or its pharmacy acceptable salt.

All steric isomers expection of The compounds of this invention exists with mixture or with pure or pure substantially form.The definition that is used for the compound of the inventive method comprises all possible steric isomer and their mixture.This definition also comprises racemic form and has the isolating optical isomer of sp act.Described racemic form can split by fractional crystallization, separation or the crystallization of physical method such as non-mapping derivative or split by the chiral column chromatography.Method by routine as with a kind of optical activity acid form the salt subsequent crystallisation can by as described in racemic modification obtain single optical isomer.

The solvate (as hydrate) that should be appreciated that formula I compound and described midbody compound also within the scope of the invention.The method of solvate is normally known in the art.Therefore, the described compound that uses in the inventive method can be the form of free form or hydrate.

Described in flow process 1, the method for preparing 5-(2- azoles base alkylthio)-2-azacycloalkanoyl aminothiazoles and analogue comprises following conversion:

(a) the ketone II of alpha-substitution such as α-Lu Daitong and trinitride are reacted in The suitable solvent or solvent mixture, obtain α-azido-ketone III; Or more desirably, (a ') reacts the ketone II of alpha-substitution such as α-Lu Daitong and ring alkylidene group tetramine such as vulkacit H in The suitable solvent or solvent mixture, obtain a kind of new quaternary ammonium salt III '.

Described α-Lu Daitong comprises alpha-halogen aliphatic series and alpha-halogen aromatic ketone.Preferred α-Lu Daitong is the alpha-halogen Pinacolone, most preferably alpha-brominated Pinacolone.A kind of sulphonate, for example RSO ₂O-(wherein R is alkyl, aryl or heteroaryl), CF ₃SO ₂O-etc. can replace halogen in the α position.Described trinitride comprises two kinds of metal azide and quaternary ammonium trinitride.Preferable alloy trinitride, most preferably sodiumazide.The suitable solvent comprises as hydrocarbon, ether, acid amides for example dimethyl formamide, ketone etc. or their mixture, for (a) and (a ') two preferred ketone of reaction such as acetone.

(b) α-azido-ketone III that in step (a), obtains with go back original reagent and in The suitable solvent or solvent mixture, react, obtain a kind of alpha-amino group ketone IV, or more desirably, the quaternary ammonium salt III ' that (b ') obtains in step (a ') reacts in The suitable solvent or solvent mixture with a kind of acid, obtains alpha-amino group ketone IV.

The reduction reagent of reaction in (b) be included in a kind of transition-metal catalyst such as palladium, trialkyl or triaryl phosphine such as triphenylphosphine in the presence of hydrogen.The preferred hydrogen in the presence of transition-metal catalyst, most preferably hydrogen and be stated from palladium on the activated carbon.Suitable solvent in reaction (b) comprises the solvent such as hydrocarbon, ether, alcohol etc., or their mixture, preferred alcohols such as methyl alcohol.As selection, this reduction reaction can be carried out in a kind of ethanolic soln of acidic intermedium example hydrochloric acid so that obtain alpha-amino group ketone acid salt, and it can be used as the isolated in form of the salt or the unhindered amina of described acid.

Acid in reaction (b ') includes, but not limited to proton transfer acid (protic acid) as HCl, HBr, HI, H ₂SO ₄, H ₃PO ₄Deng, preferred HCl.Suitable solvent in reaction (b ') comprises the solvent such as hydrocarbon, ether, alcohol etc., or their mixture, preferred alcohols such as ethanol.Can be with the described alpha-amino group ketone of the isolated in form of salt or free alkali product

(c) in the presence of alkali and in The suitable solvent or solvent mixture, make acid salt that described alpha-amino group ketone IV or it obtains in step (b) or (b ') and a kind of acyl derivative V such as alpha-halogen acyl halide reaction (acidylate) of alpha-substitution obtain acid amides VI.

Described alpha-halogen acyl halide V comprises alpha-alkyl or aryl is that replace or unsubstituted alpha-halogen acyl halide, the preferred latter.Most preferred alpha-halogen acyl halide is α-chloroacetyl chloride.The alkali that is used for this reaction includes, but not limited to the organic amine of aromatics and aliphatic series, the preferred latter.Most preferred alkali is triethylamine.The suitable solvent comprises aprotonic solvent such as hydrocarbon, halohydrocarbon, ether, ester etc., or their mixture, preferred halohydrocarbon such as methylene dichloride.As selection, the acyl derivative of the acid substitution alpha-substitution of available a kind of alpha-substitution carries out this reaction with a kind of coupling reagent such as a kind of water miscible diimine such as carbodiimide, haloformate, thionyl halide etc. then.In any one reaction, a kind of sulphonate is as RSO therein ₂O-(wherein R is alkyl, aryl or heteroaryl), CF ₃SO ₂O-etc. can replace halogen in the α position of alpha-halogen acyl halide of being set forth or alpha-halogen acid reaction.

(d) the acid amides VI and a kind of dehydrated reagent that obtain in step (c) are reacted in The suitable solvent or solvent mixture, obtain ring-type 2- azoles base alkyl derivative VII such as 2- azoles base alkyl halide.

Easily, carry out this reaction with hydroxide (methoxycarbonyl sulfamyl)-triethyl ammonium (Burgess ' reagent) as dehydrated reagent.The suitable solvent comprises hydrocarbon, halohydrocarbon, ether etc., or their mixture.Most preferably in tetrahydrofuran (THF), use Burgess ' reagent.Suitable dehydrated reagent also includes, but not limited to other alkali, acid, acid anhydrides etc., as the vitriol oil, Tripyrophosphoric acid etc.For example, though inconvenient, described dehydrated reagent can be for separately or with three halo phosphorus oxide such as the phosphorus oxybromide or the phosphoryl chloride of solvent such as toluene.

(e) the 2- azoles base alkyl derivative VII that obtains and a kind of sulfur-bearing regent VIII or VIII ' are reacted in The suitable solvent or solvent mixture, obtain 2- azoles base alkyl sulfur compounds IX, a kind of new key intermediate compound.

Described sulfur-bearing regent comprises that N-replaces or unsubstituted thiocarbamide, thioic acid sulfoacid or salt such as thioacetic acid or its salt, xanthogenic acid or salt such as xanthogenic acid sylvite.Preferred unsubstituted thiocarbamide.The suitable solvent comprises hydrocarbon, halohydrocarbon, ether, ester, acid amides, alcohol etc., or their mixture, preferred alcohols such as methyl alcohol or ethanol.

(f) in the presence of a kind of alkali and in The suitable solvent or solvent mixture, make the 2- azoles base alkyl sulfur compounds IX and a kind of 5-halo-thiazolamine X reaction that in step (e), obtain, obtain 5-(2- azoles base alkylthio)-thiazolamine XI.

Described 5-halo-thiazolamine comprises 4, replace or the unsubstituted 5-halo-thiazolamine of N-, preferred 5-bromo-thiazolamine.Suitable alkali includes, but not limited to metal hydroxides, metal alkoxide, metal carbonate and water-soluble amine such as ammonium hydroxide.Preferred sodium hydroxide.The suitable solvent comprises such as hydrocarbon, halohydrocarbon, ether, ester, acid amides, pure equal solvent, or their mixture, preferred halon such as methylene dichloride.

(g) in the presence of a kind of coupling reagent, in The suitable solvent or solvent mixture, 5-(2- azoles base the alkylthio)-thiazolamine XI that obtains in step (f) is reacted with a kind of azacycloalkyl acid derivative XII, obtain Thizaolyl amide XIII.

Described azacycloalkyl acid derivative comprises the derivative of N-protected, for example the different piperidine carboxylic acid of N-protected or the nipecotic acid of N-protected.Preferred nitrogen-blocking group is Boc, Cbz, silicon derivative etc., most preferably Boc.Described coupling reagent includes, but not limited to water miscible carbodiimide, haloformate etc., preferred carbodiimide such as alkyl carbodiimide.The suitable solvent comprises as all hydrocarbon, halon, ether, ester, acid amides equal solvent, or their mixture, preferred halon such as methylene dichloride.

(h) make in step (g) the Thizaolyl amide XIII that obtains and a kind ofly go to protect reagent in The suitable solvent or solvent mixture, to react, obtain required 5-(2- azoles base alkylthio)-2-azacycloalkanoyl aminothiazoles I (R wherein ⁷Be hydrogen).

Described selection of removing to protect reagent is based on the character of blocking group (P); for the Boc blocking group; preferably removing to protect reagent is sour example hydrochloric acid or trifluoroacetic acid; and the suitable solvent that is used for this type of protective reaction comprises such as hydrocarbon, halon, ether, ester, acid amides equal solvent; or their mixture, preferred halon such as methylene dichloride.

The initial compounds of flow process 1 is commercial maybe can preparing by the known method of those of ordinary skills of can obtaining.

For the further flow process 1 of setting forth, a kind of method for preparing 5-(the 5-tertiary butyl-2- azoles ylmethyl thio group)-2-azacycloalkanoyl aminothiazoles and its analogue, for example, by alpha-brominated Pinacolone II (the R=tertiary butyl, R ¹=H L=Br) begins to obtain α-azido-Pinacolone III (the R=tertiary butyl, R with reaction of sodium azide ¹=H).With a kind of original reagent reduction α-azido-Pinacolone III (the R=tertiary butyl, R that go back ¹=H) obtain alpha-amino group Pinacolone IV (the R=tertiary butyl, R ¹=H).As selecting and better being, by alpha-brominated Pinacolone II (the R=tertiary butyl, R ¹=H is L=Br) with the vulkacit H reaction, with quaternary ammonium salt III ' (the R=tertiary butyl, the R of posthydrolysis generation ¹=H, L=Br) described alpha-amino group Pinacolone IV (the R=tertiary butyl, R of preparation ¹=H).Make alpha-amino group Pinacolone IV (the R=tertiary butyl, R ¹=H) with a kind of α-chloroacetyl chloride V (R ²=R ³=H, L=X=Cl) coupling produces acid amides VI (the R=tertiary butyl, R ¹=R ²=R ³=H, L=Cl).Make the VI closed loop obtain the 5-tertiary butyl-2- azoles ylmethyl chlorine VII (the R=tertiary butyl, R with a kind of dehydrated reagent ¹=R ²=R ³=H, L=Cl).Reagent VIII or VIII ' with sulfur-bearing obtain the 5-tertiary butyl-2- azoles base alkyl sulfur compounds IX (the R=tertiary butyl, R as thiocarbamide processing VII ¹=R ²=R ³=H, Y=NH, Z=NH ₂).IX and 5-bromo-thiazolamine X (R ⁴=R ⁵=H, L=Br) coupling obtains 5-(the 5-tertiary butyl-2- azoles ylmethyl thio group)-thiazolamine XI (the R=tertiary butyl, R ¹=R ²=R ³=R ⁴=R ⁵=H).XI and N-Boc nitrogen heterocyclic alkanoic acid XII (X=OH, R ⁶=R ⁷=H, m=0, n=2, P=Boc) coupling obtains thiazole acid amides XIII (the R=tertiary butyl, R ¹=R ²=R ³=R ⁴=R ⁵=R ⁶=R ⁷=H, m=0, n=2 P=Boc), is going to protect the back to obtain required 5-(the 5-tertiary butyl-2- azoles ylmethyl thio group)-2-azacycloalkanoyl aminothiazoles I (the R=tertiary butyl, R ¹=R ²=R ³=R ⁴=R ⁵=R ⁶=R ⁷=R ⁸=H, m=0, n=2), or its analogue.

For 5-(2- azoles base alkylthio)-2-azacycloalkanoyl aminothiazoles of synthesis type I, the present invention also comprises two kinds of new key intermediate compound formula IIIs ' and IX, prepares this two kinds of midbody compounds by described novel method.

Below implement to show card some aspect of the present invention., should be appreciated that these embodiment only illustrate, and do not mean that and be limited to condition of the present invention and scope fully.Should be appreciated that,, also can use the above or following condition of specialized range, although generally inconvenient when having provided typical reaction conditions when (as temperature, reaction times etc.).Described embodiment carries out under room temperature (about 23 ℃ to 28 ℃) and normal atmosphere.All parts and per-cent are expressed with centigradetemperature based on weight and all temperature at this, unless otherwise indicated.

Can obtain further understanding of the present invention from following non-restrictive example.

Embodiment 1

A. prepare α-azido-Pinacolone

With alpha-brominated-Pinacolone (199.07g, 1.1115mol, 1eq) merge to 1.785L acetone and sodiumazide (93.9g, 1.4444mol, 1.3eq) in.At room temperature stirred this reactant 27.5 hours.Also (3 * 150ml) washings concentrate this filtrate under vacuum, obtain 154.3g (98.4%) title compound with acetone to filter the soup compound that is produced.HPLC:83.85%, 2.57 minutes (Phenomenex Inc., Torrance, CA, 5 μ m C18 posts, 4.6 * 50mm contains the 10-90% methanol aqueous solution 4 minutes of 0.2% phosphoric acid, and 4ml/ minute, in the monitoring of 220nm place).

Embodiment 2

A '. preparation α-hexamethylene tetraammonia base-Pinacolone bromide

(179g, 1mol 1eq) incorporate 2L into and contain vulkacit H (154.21g, 1.1mol is in acetone 1.1eq) and at N with alpha-brominated-Pinacolone ₂, stirred this reactant 26 hours under the room temperature.Filter the soup compound produced, with ether (3 * 50ml) wash this filter cake and under vacuum, 50 ℃ of dried overnight, obtain the title compound that 330g (100%) contains 7% vulkacit H.HPLC:R.T.=0.17 minute (5 μ m C18 posts, 4.6 * 50mm contains the 10-90% methanol aqueous solution 4 minutes of 0.2% phosphoric acid for Phenomenex Inc., Torrance, and 4ml/ minute, in the monitoring of 220nm place).

Embodiment 3

B. prepare alpha-amino group-Pinacolone hydrochloride

(128.5g 0.911mol) merges in the 4.2L methyl alcohol of the 10%Pd/C that contains dense HCl of 77.1ml and 15.42g with α-azido--Pinacolone.Under hydrogen, stirred this reaction mixture 1.5 hours.By this catalyzer of filtering and removing.The solid that solvent distillation obtains wetting.(2 * 500ml) azeotropic remove remaining water with Virahol.Add t-butyl methyl ether (300ml) and stir the soup compound that produces, filter, (3 * 100ml) washings and drying obtain the title compound of 131.0g (95.5%) with t-butyl methyl ether.

Embodiment 4

B '. preparation alpha-amino group-Pinacolone hydrochloride

With α-hexamethylene tetraammonia base-Pinacolone bromide (400g, 1.254mol, 1eq) incorporate into the 2L ethanol and the 12N HCl aqueous solution (439ml, 5.26mol, 4.2eq) in.Down stirred these reactants 1 hour at 75 ℃, allow it be cooled to room temperature then, filter the soup compound that produces, concentrated filtrate and add Virahol under vacuum.Refilter this solution.Add the 1.2L ether, required material is precipitated from solution.Filter this material, with ether (2 * 300ml) washings, and, obtain 184.1g (97%) title compound in 50 ℃ of dried overnight in a vacuum.

Embodiment 5

C. prepare α-N-(2-chloro acetylamino)-Pinacolone

At-5 ℃, N ₂Down, (130.96g, 0.8637mol 1eq) are dissolved in the 3.025L methylene dichloride with the title compound of embodiment 4.Add triethylamine (301 ml, 2.16mol, 2.5eq), be added in subsequently chloroacetyl chloride in the 175ml methylene dichloride (75.7ml, 0.450mol, 1.1eq).-5 to-10 ℃ of soup compounies that stir to produce 2 hours.Add entry (1.575L), add the dense HCl of 175ml subsequently.The HCl aqueous solution with 1.75L 10% washs organic phase once more, uses the 500ml water washing then.This organic phase concentrates through dried over sodium sulfate and under vacuum, obtains 155.26g (93.8%) title compound.HPLC:R.T.=2.27 minute (Phenomenex Inc., 5 μ m C18 posts, 4.6 * 50mm contain the 10-90% methanol aqueous solution 4 minutes of 0.2% phosphoric acid, and 4ml/ minute, in the monitoring of 220nm place).

Embodiment 6

D. prepare 5-(tertiary butyl)-2- azoles ylmethyl chlorine

At N ₂Down, (1eq) (262ml, 2.8109mol 3eq) merge with phosphoryl chloride for 180.13g, 0.9398mol with the title compound of embodiment 5.Heated these reactants 1 hour at 105 ℃, cool off this mixture and ice cancellation to room temperature and with 1.3kg.(1L 2 * 500ml) extracts this water then with ethyl acetate.(4 * 1L) these organic extracting solutions of washing, this saturated sodium bicarbonate aqueous solution returns with ethyl acetate to be carried several times with saturated sodium bicarbonate aqueous solution.Merge organic phase,, use saturated sodium-chlor (300ml) washing subsequently, concentrate, obtain a kind of brown oil through dried over mgso and under vacuum with saturated sodium bicarbonate aqueous solution (500ml) washing.This crude product material of distillation under 100 ℃, high vacuum obtains the title compound of 155.92g (96%).HPLC:R.T.=3.62 minute (Phenomenex Inc., 5 μ m C18 posts, 4.6 * 50mm contain the 10-90% methanol aqueous solution 4 minutes of 0.2% phosphoric acid, and 4ml/ minute, in the monitoring of 220nm place).

As selection; will be at the title compound (10.0g of the embodiment 5 in the 50ml tetrahydrofuran (THF) (THF); 52.17mmol; 1eq) with hydroxide (methoxycarbonyl sulfamyl)-triethyl ammonium (Burgess ' reagent; 105.70mmol; 2.03eq. original position produces from the 9.2ml chloro sulfonyl isocyanate among 100ml THF, 4.4ml methyl alcohol and 14.8ml triethylamine) merge.Heat this reactant to 45 ℃ 1.5 hours.Behind cool to room temperature, water (50ml) cancellation should reaction.Separate this organic layer and with saturated sodium bicarbonate (2 * 50ml) and water (50ml) washing, also pass through a little silica gel plug through dried over mgso.Remove solvent and obtain a kind of oily matter, it is dissolved in the mixture of 15ml heptane and 90ml t-butyl methyl ether, use then 0.2N HCl (2 * 25ml), the washing of saturated salt solution (25ml) and dry (sal epsom).Filtration also removes solvent, obtains the 10.9g title compound.

Embodiment 7

E. prepare 5-(tertiary butyl)-2- azoles ylmethyl thiocarbamide  hydrochloride

At N ₂Down, (1.02eq) (0.76g, 9.98mmol 1eq) merge in the 10ml dehydrated alcohol with thiocarbamide for 1.77g, 10.2mmol with the title compound of embodiment 6.This reactant of heating is .5 hour under refluxing.Cooling off this mixture concentrates to room temperature and under vacuum.Grind the raw product that produces with t-butyl methyl ether, obtain the title compound of 2.32g (93%).HPLC:R.T.=2.05 minute (Phenomenex Inc., 5 μ m C18 posts, 4.6 * 50mm contain the 10-90% methanol aqueous solution 4 minutes of 0.2% phosphoric acid, and 4ml/ minute, in the monitoring of 220nm place); ¹HNMR (d ₆-DMSO): δ 9.48 (s, 3H), 6.85 (s, 1H), 4.73 (s, 2H), 1.24 (s, 9H).

Embodiment 8

F. prepare 5-[5-(tertiary butyl)-2- azoles methylthiol]-thiazolamine

With the title compound of embodiment 7 (1.25g, 5mmol, 1eq) join NaOH (3.0g, 75mmol, 15eq), (50mg, 0.086mmol is in mixture 0.017eq) for water (10ml), toluene (10ml) and sulfuric acid TBuA.(1.70g, 5mmol 1eq) also at room temperature stirred this reactant 14.5 hours to add 5-bromo-thiazolamine hydrobromate.This mixture of dilute with water is also used ethyl acetate extraction twice, and (4 * 10ml) these organic extracting solutions of washing concentrate through dried over mgso and under vacuum water, obtain the title compound of 1.1g (82%).HPLC:86.3%2.75 minute (Phenomenex Inc., 5 μ m C18 posts, 4.6 * 50mm contain the 10-90% methanol aqueous solution 4 minutes of 0.2% phosphoric acid, and 4ml/ minute, in the monitoring of 220nm place); ¹H NMR (CDCl ₃-DMSO): δ 6.97 (s, 1H), 6.59 (s, 1H), 5.40 (br s, 2H), 3.89 (s, 2H), 1.27 (s, 9H).

Embodiment 9

G. prepare 5-[5-(tertiary butyl)-2- azoles methylthiol]-the 2-[(N-tert-butoxycarbonyl) azacycloalkanoyl] aminothiazole

Title compound (9.6g with embodiment 8,35.6mmol) be dissolved in N, in dinethylformamide (36ml) and the methylene dichloride (100ml), to wherein add 1-(3-dimethylaminopropyl)-3-ethyl-carbodiimide hydrochloride (13.8g, 72mmol, 2eq), N-tert-butoxycarbonyl-nitrogen heterocyclic alkanoic acid (12.6g, 55mmol, 1.5eq) and 4-(dimethylamino) pyridine (2g, 16mmol, 0.45eq).When at room temperature stirring 3.5 hours, it is muddy that this limpid reaction mixture becomes.The precipitation that adds entry (300ml) and ethyl acetate (200ml) and produce by filtering and removing.With this filtrate of ethyl acetate extraction, organic extracting solution concentrates through dried over mgso and under vacuum, obtains the xanchromatic solid, and this solid and the precipitation of filtering acquisition are merged.In the mixture of ethanol, acetone and water, boiled this solid 20 minutes, and filtered, wash and drying, obtain 16.6g (97%) title compound with ethanol/water mixture.

Embodiment 10

Preparation 5-[5-(tertiary butyl)-2- azoles methylthiol]-2-(azacycloalkanoyl) aminothiazole hydrochloride

The title compound (16.6g) of embodiment 9 is dissolved in the 150ml methylene dichloride, drips trifluoroacetic acid (30ml), at room temperature stirred this mixture 2 hours.Concentrate this reactant under vacuum, water (300ml) dilution is cooled off in ice, with the sodium hydroxide alkalization, filter the solid that produces and in ethanol, water and methyl alcohol recrystallization, obtain 11.2g (83%) title compound, a kind of yellow solid.By being joined, the 18ml 1N HCl aqueous solution obtains the white solid hydrochloride in this material of 7g in methyl alcohol.MS:381[M+H] ⁺HPLC:100%3.12 minute (YMC S5 ODS post 4.6 * 50mm contains the 10-90% methanol aqueous solution 4 minutes of 0.2% phosphoric acid, and 4ml/ minute, in the monitoring of 220nm place).

For the purpose of setting forth rather than limiting, in aforementioned, provide the detailed description of specific embodiments of the present invention.Should be appreciated that, on basis of the present disclosure, conspicuous all other modification, branch and the Equivalent of those skilled in the art all planned to be included in as in the claimed scope of the present invention.

Claims (6)

1. One kind prepare have formula III ' the method for compound or its salt:

   

   Wherein:

   R is the tertiary butyl;

   R ¹Be hydrogen, alkyl, aryl or heteroaryl; With

   L is halogen or sulphonate;

   This method is included in The suitable solvent or the solvent mixture, makes the ketone of the alpha-substitution with formula II and the reaction of ring alkylidene group tetramine form formula III ' compound;

   

   In formula II: R, R ¹With L as mentioned above.
2. 2. in accordance with the method for claim 1, wherein said ring alkylidene group tetramine is a vulkacit H.
3. One kind have formula III ' compound or its salt

   Wherein:

   R is the tertiary butyl;

   R ¹Be hydrogen, alkyl, aryl or heteroaryl; With

   L is halogen or sulphonate;
4. 4. according to the described compound of claim 3, wherein R ¹Be hydrogen.
5. 5. according to the described compound of claim 4, wherein L is a halogen.
6. 6. according to the described compound of claim 5, it is α-hexamethylene tetraammonia base-Pinacolone bromide.